OakChart

SkinHealth Systems Inc

SKINConsumer Defensive·Household & Personal Products·USA·Micro·NASD·Nov 11 • 3:59 PM ET

16.67+0.73 (4.58%)
2026-11-12 05:57 CET
Market cap
109.06 USD m
Revenue, TTM
288.59 USD m
Net income, TTM
-18.29 USD m
Free cash flow, TTM
22.69 USD m
EPS diluted, TTM
-2.90
P/E
-
Compare

Price

SKIN against its 20, 50 and 200-day averages
2050200beat
10.0015.0020.0025.0030.002.2M4.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SKINclose 16.6720-day 11.8250-day 12.47200-day 16.0416.6752w low

49.5% under the 52-week high of 33.00 on 5 Dec 2025. 52-week low 9.68 on 30 Oct 2026. Last 15 sessions, 86.0% high to low

Volume 2.14× normal · the line is the 50-bar volume average

Profile

SKIN
52-week range, 30% of the way up
9.6833.00

Skinhealth Systems, Inc. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.

Employees613
IPONov 24, 2020
Beta0.96
ATR, 14d1.35
Rel volume2.14
Short float8.92%
Insider own38.63%
Inst own44.70%

Snapshot

6 groups

Valuation

Index-
Market Cap109.07M
Enterprise Value260.92M
Income-18.29M
Sales288.59M
Book/sh8.56
Cash/sh17.18
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees613
IPONov 24, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S0.38
P/B1.95
P/C0.97
P/FCF4.81
EV/EBITDA9.28
EV/Sales0.90
Quick Ratio2.22
Current Ratio2.89
Debt/Eq4.74
LT Debt/Eq4.67
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.90
EPS next Y-0.92
EPS next Q-0.46
EPS this Y-54.11%
EPS next Y62.73%
EPS next 5Y25.84%
EPS past 3/5Y11.04% 28.16%
Sales past 3/5Y-6.32% 20.36%
EPS Y/Y TTM-51.42%
Sales Y/Y TTM-4.41%
EPS Q/Q92.15%
Sales Q/Q-2.10%
EarningsNov 05 AMC
EPS/Sales Surpr.89.51% 1.81%

Ownership

Insider Own38.63%
Insider Trans0.00%
Inst Own44.70%
Inst Trans-
ROA-4.10%
ROE-30.12%
ROIC-5.78%
Gross Margin67.23%
Oper. Margin2.41%
Profit Margin-6.34%
SMA2041.09%
SMA5033.68%
SMA2003.96%
Trades-

Technical

Shs Outstand6.51M
Shs Float4.02M
Short Float8.92%
Short Ratio10.13
Short Interest0.36M
52W High33.00 -49.48%
52W Low9.68 72.21%
Volatility16.72% 11.51%
ATR (14)1.35
RSI (14)70.59
Beta0.96
Rel Volume2.14
Avg Volume35.40K
Volume75,737

Performance

Perf Week50.86%
Perf Month54.18%
Perf Quarter26.29%
Perf Half Y28.23%
Perf YTD-40.04%
Perf Year-36.37%
Perf 3Y-76.85%
Perf 5Y-96.59%
Perf 10Y-
Recom3.22
Target Price14.00
Prev Close15.94
Price16.67
Change %4.58%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 19, 2025InitiatedRRoth CapitalBuy$3.50-79.0%
Nov 15, 2023DowngradeJJefferiesBuy → Hold$11 → $1.50-91.0%
Nov 14, 2023DowngradeWWilliam BlairOutperform → Mkt Perform
Nov 14, 2023DowngradeTThe Benchmark CompanyBuy → Hold
Nov 14, 2023DowngradeTTD CowenOutperform → Market Perform$9 → $2.50-85.0%
Nov 14, 2023DowngradeRRaymond JamesMkt Perform → Underperform
Nov 14, 2023DowngradePPiper SandlerOverweight → Underweight$12 → $2-88.0%
Nov 14, 2023DowngradeJJP MorganNeutral → Underweight
Nov 14, 2023DowngradeCCanaccord GenuityBuy → Hold$10 → $2.50-85.0%
Aug 25, 2023ResumedCCanaccord GenuityBuy$10-40.0%

Peers

Mkt cap
TickerCompanyMkt cap
INMDInmode Ltd790.08M
APYXApyx Medical Corp126.37M
NUSNu Skin Enterprises Inc189.36M
ELFe.l.f. Beauty Inc7.01B
ODDODDITY Tech Ltd917.88M
HNSTHonest Company Inc556.33M
EOLSEvolus Inc491.11M
AIRSAirsculpt Technologies Inc59.55M
ESTAEstablishment Labs Holdings Inc2.11B
BHCBausch Health Companies Inc3.13B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Menezes RonaldFormer OfficerMay 20 '26Proposed Sale0.69165,000114,532May 20 04:25 PM
BECK MARLA MALCOLMFormer Officer & DirectorDec 05 '25Proposed Sale1.615,0008,074Dec 05 01:04 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200
  • SkinHealth Systems (SKIN) Beats On Cost Discipline And A Consumables Recovery, But Device Weakness And A Narrowed Sales Outlook Temper The Turnaround (Earnings Whispers) -6.33% +51.79%
  • SkinHealth Systems Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • BeautyHealth's Rental Program Gets Its First Test As Shrinking Revenue Meets Debt Payoff (Earnings Whispers)
  • SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire)
  • SkinHealth Systems Announces Reverse Stock Split (GlobeNewswire)
  • Hydrafacial Introduces HydraClear Treatment Booster to Clarify Blemish-Prone Skin (GlobeNewswire)
  • SkinHealth Systems Expands SkinStylus SteriLock MicroSystem to Europe (GlobeNewswire)
  • SkinHealth Systems Unveils New Hydrafacial and HydraScalp with Keravive Clinical Data at the 2026 Science of Skin Summit (GlobeNewswire)
  • Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers (GlobeNewswire) +7.61%
  • SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth (GlobeNewswire) +5.37%
  • SkinHealth Systems Inc (SKIN) (Q2 2026) Earnings Call Highlights: Strong EBITDA Beat and ... (GuruFocus.com) -13.91%
  • SkinHealth Systems Reports Second Quarter 2026 Financial Results (GlobeNewswire) +8.88%
  • SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026 (GlobeNewswire)
  • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types (GlobeNewswire) +47.04%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.140-1.335-0.14069.2067.978
2026Q22026-08-06-0.400-0.500-0.41272.1074.458
2026Q12026-05-07-1.000-1.480-1.08464.9066.288
2025Q42026-03-12-1.200-0.968-1.27182.4078.208
2025Q32025-11-06-1.800-1.478-1.73970.7068.559
2025Q22025-08-073.200-1.0580.59478.2074.547
2025Q12025-05-08-1.600-2.564-1.61469.6063.118
2024Q42025-03-12-1.600-2.276-1.66183.5077.198
2024Q32024-11-12-3.000-1.846-2.94978.8077.019
2024Q22024-08-08-1.140-0.300-2.03690.6098.499
2024Q12024-05-09-0.200-2.076-1.90481.4080.568
2023Q42024-03-12-0.560-1.476-1.46196.8087.2210
2023Q32023-11-13-9.9961.482-11.10997.40116.2210
2023Q22023-08-091.2180.9360.507117.5114.8910
2023Q12023-05-10-0.848-0.566-3.36686.3090.3510
2022Q42023-02-281.1180.7860.55298.1394.7310

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-3.300--17.015119.1-
2021FY0.9441.730-73.468260.09253.29
2022FY1.6481.182-4.625365.88362.43
2023FY-9.580-1.512-15.206398388.65
2024FY-4.600-5.644-7.266334.3327.92
2025FY-1.600-1.437-1.600300.8296.75
2026FY--2.466--285.02
2027FY--0.919--289.5
2028FY--0.653--305.66
2029FY-0.180--334
2030FY-0.490--355

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0690479.3077.9081.04
2026Q4S2026-11-0390179.8577.9081.49
2026Q4S2026-10-2490279.8577.9081.49
2026Q4S2026-10-2190379.8577.9081.49
2026Q4S2026-10-1591580.2377.9083.21
2026Q4S2026-08-2091580.2077.9083.21
2026Q4S2026-08-1191480.3277.9083.21
2026Q4S2026-08-1091480.3877.9083.21
2026Q4S2026-08-0791380.9478.0083.21
2026Q4S2026-08-0291081.5479.0083.04
2026Q4S2026-07-2991181.5479.0083.04
2026Q4S2026-07-2291281.5479.0083.04
2026Q4S2026-07-1391581.5479.0083.04
2026Q4S2026-05-2790781.2077.0083.04

Estimate history

EPS, annual-1.019-17.015-73.468-4.625-15.206-7.266-3.256-2.9032
Period2019202020212022202320242025TTM
EPS, quarterly-2.949-1.661-1.6140.594-1.739-1.271-1.084-0.412-0.136
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual166.623119.092260.086365.876397.991334.294300.79288.59
Period2019202020212022202320242025TTM
Sales, quarterly78.80283.49569.5878.18770.65582.464.9172.11369.171
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1.6071.7757.536.6116.1456.2466.3766.513
Period2019202020212022202320242025MRQ
Shares, quarterly6.2066.2466.2626.3386.3656.3766.4576.5056.513
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue288.59300.79334.29397.99365.88260.09119.09166.62
Cost of Goods Sold Incl. D&A94.57104.43144.00242.88117.1085.7355.6762.52
Gross Profit194.02196.36190.30155.11248.78174.3663.42104.10
Selling, General and Administrative Excl. Other187.07217.17250.07278.83274.62172.0772.0890.64
Research and Development5.875.636.3010.108.448.203.414.61
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income6.95-20.80-59.77-123.72-25.842.29-8.6613.46
Interest Expense25.3119.3310.4113.6513.3911.7821.2717.09
Unusual Expense-0.10-0.494.93-4.72-78.34363.058.520.00
Net Income Before Taxes-13.18-5.94-29.55-101.8945.34-377.35-38.48-2.94
Income Taxes5.103.58-0.45-1.771.11-2.24-9.31-1.30
Consolidated Net Income-18.29-9.52-29.10-100.1244.22-375.11-29.18-1.64
Net Income From Continuing Operations-18.29-9.52-29.10-100.1244.22-375.11-29.18-1.64
Net Income-18.29-9.52-29.10-100.1244.22-375.11-29.18-1.64
EPS (Recurring)-2.90-3.31-6.78-15.71-11.98-23.69-13.54-1.02
EPS (Basic, Before Extraordinaries)-2.86-1.51-4.70-15.215.99-73.47-17.02-1.02
EPS (Diluted)-2.90-3.26-7.27-15.21-4.62-73.47-17.02-1.02
EBITDA28.120.03-30.30-91.48-3.8323.435.7427.20
Non-Operating Income (Expense)5.0833.7045.5730.766.23-4.82-0.030.69
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.9111.7121.0917.8122.519.070.260.08
Price To Sales Ratio0.280.630.681.033.699.493.26-
Gross Margin67.2365.2856.9238.9768.0067.0453.2662.48
Operating Margin2.41-6.92-17.88-31.09-7.060.88-7.278.08
Net Margin-6.34-3.16-8.70-25.1612.09-144.22-24.50-0.98
Shares Outstanding6.516.386.256.146.617.531.781.61
Market Capitalization109.06109.06198.63412.291,303.133,638.45650.33653.20

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue69.1772.1164.9182.4070.6678.1969.5883.50
Cost of Goods Sold Incl. D&A22.0222.7720.4729.3025.0229.0721.0031.15
Gross Profit47.1549.3444.4453.1045.6349.1148.5852.35
Selling, General and Administrative Excl. Other42.1745.7746.2452.9051.8851.8160.6059.50
Research and Development1.661.411.101.701.701.251.001.22
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income4.983.57-1.800.20-6.24-2.70-12.02-7.16
Interest Expense6.276.296.356.406.314.142.502.46
Unusual Expense0.000.000.00-0.10-0.210.21-0.35-0.07
Net Income Before Taxes-0.11-1.46-6.81-4.80-10.6418.72-9.20-11.72
Income Taxes0.781.21-0.183.300.39-0.990.89-1.39
Consolidated Net Income-0.89-2.67-6.63-8.10-11.0319.71-10.10-10.33
Net Income From Continuing Operations-0.89-2.67-6.63-8.10-11.0319.71-10.10-10.33
Net Income-0.89-2.67-6.63-8.10-11.0319.71-10.10-10.33
EPS (Recurring)-0.14-0.41-1.08-1.28-1.760.61-1.65-1.67
EPS (Basic, Before Extraordinaries)-0.14-0.41-1.04-1.27-1.743.13-1.61-1.66
EPS (Diluted)-0.14-0.41-1.08-1.27-1.740.59-1.61-1.66
EBITDA10.258.843.545.502.192.70-5.86-0.60
Non-Operating Income (Expense)1.191.261.331.301.7025.774.97-2.17
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.142.291.642.841.944.192.754.62
Price To Sales Ratio0.280.310.390.590.840.860.520.59
Gross Margin68.1668.4268.4664.4464.5962.8169.8262.69
Operating Margin7.204.95-2.770.24-8.83-3.45-17.28-8.57
Net Margin-1.28-3.70-10.21-9.83-15.6125.21-14.51-12.37
Shares Outstanding6.516.516.466.386.376.346.266.25
Market Capitalization109.0690.10114.94177.25253.33242.12167.83198.63

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments232.67370.06523.02568.20901.899.49-
Short Term Receivables23.4429.4670.0383.7751.4223.19-
Inventories48.0169.1191.32109.6635.2623.20-
Other Current Assets5.398.4913.8821.6512.323.22-
Total Current Assets309.52477.12698.25783.271,000.8959.09-
Net Property, Plant & Equipment14.1119.5726.3533.8231.189.19-
Total Investments and Advances0.000.000.000.000.000.00-
Intangible Assets162.38171.01187.94170.98179.70149.47-
Deferred Tax Assets1.933.890.530.810.330.27-
Other Assets11.8714.0916.0414.196.714.81-
Total Assets499.80685.68929.111,003.081,218.81222.84-
Short Term Debt Incl. Current Port. of LT Debt129.095.154.606.783.710.51-
Accounts Payable15.6321.9444.7728.4729.0518.48-
Income Tax Payable1.233.432.761.430.290.00-
Other Current Liabilities40.3337.6462.8835.0443.3811.93-
Total Current Liabilities186.2868.15115.0171.7176.4430.93-
Long Term Debt249.67563.01747.69746.83742.70216.02-
Provision for Risks Charges0.000.002.000.000.000.00-
Deferred Tax Liabilities0.390.400.702.013.563.99-
Other Liabilities2.412.324.3215.4793.821.85-
Total Liabilities438.75633.88869.72836.03916.51252.79-
Non-Equity Reserves0.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.000.00-
Common Equity61.0651.8059.39167.05302.30-29.96-
Total Shareholders Equity61.0651.8059.39167.05302.30-29.96-
Accumulated Minority Interest0.000.000.000.000.000.00-
Total Equity61.0651.8059.39167.05302.30-29.96-
Total Liabilities & Stockholders Equity499.80685.68929.111,003.081,218.81222.84-
Book Value Per Share9.588.299.6625.2740.15-16.88-
Tangible Book Value Per Share-15.89-19.08-20.92-0.5916.28-101.08-
Full-Time Employees613769881881704406-
Price to Book Ratio1.953.834.585.0512.04130.06-
Return on Assets-1.61-3.60-10.333.98-44.58--
Return on Equity-16.87-52.34-86.7318.84-100.10--
Return on Invested Capital-3.06-4.73-12.404.84-35.90-15.68-
Quick Ratio1.405.995.289.3912.631.16-
Current Ratio1.667.006.0710.9213.091.91-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-18.29-9.52-29.10-100.1244.22-375.11-29.18-1.64
Depreciation16.7120.8429.4832.2422.0221.1414.4013.88
Other Funds (Non Cash)31.4013.5846.9066.27-27.57348.049.262.05
Funds from Operations29.2227.1143.53-1.6138.67-9.70-9.859.64
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-5.6410.37-27.3923.36-145.27-18.66-2.58-7.91
Income Taxes Payable---1.280.67-0.59-2.962.52
Cash from Operating Activities23.5837.4816.1321.75-106.60-28.36-12.441.73
Capital Expenditures-5.30-5.16-6.79-13.05-17.39-15.62-3.82-10.42
Net Assets From Acquisitions0.000.000.00-18.46-1.48-22.900.00-3.83
Sale of Fixed Assets and Businesses0.000.000.000.000.00357.630.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.780.000.00
Cash from Investing Activities-5.30-5.16-6.79-31.51-18.87319.90-3.82-14.25
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-1.57-1.57-1.96-35.63-160.93938.38-0.480.00
Repurchase of Common Pref Stock0.000.000.00-30.16-160.000.00-0.150.00
Sale of Common Pref Stock-1.57-1.57-1.96-5.47-0.93938.38-0.320.00
Proceedsfrom Stock Options-1.57-1.57-1.96-5.47-0.93750.00-0.320.00
Issuance or Reduction of Debt, Net114.20-173.35-156.080.000.00-336.9819.6516.35
Change in Long Term Debt114.20-173.35-156.080.000.00-336.9819.6516.35
Issuance of Long Term Debt237.60237.600.000.000.00-16.3436.4228.35
Reduction of Long Term Debt-123.40-410.95-156.080.000.00-320.64-16.77-12.00
Net Financing Active Other Cash Flow-237.780.00-0.30-1.82-44.310.00-0.900.00
Other Financing Activities Uses-0.100.00-0.30-1.82-44.310.00-0.900.00
Cash from Financing Activities-125.15-174.93-158.34-37.45-205.24601.4018.2716.35
Exchange Rate Effect-0.145.21-3.962.03-2.98-0.540.16-0.09
Net Change in Cash-107.01-137.39-152.96-45.17-333.69892.402.183.73
Free Cash Flow22.6937.1815.3817.93-117.45-39.56-15.94-7.05
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow3.615.0814.7322.85----
Deferred Taxes & Investment Tax Credit-2.22-3.750.000.00-3.76-4.34-4.65

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments112.39206.07204.36232.67219.40212.00
Short Term Receivables20.3019.6320.2523.4425.3927.13
Inventories46.2546.8447.6948.0156.1559.19
Other Current Assets22.6522.695.395.397.437.79
Total Current Assets201.59295.24277.69309.52308.37306.11
Net Property, Plant & Equipment20.8721.4822.6314.1116.6615.24
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets153.74156.57159.04162.38164.48169.76
Deferred Tax Assets2.162.352.411.930.983.16
Other Assets10.7010.9311.4511.8713.1413.30
Total Assets389.06486.57473.23499.80503.64507.56
Short Term Debt Incl. Current Port. of LT Debt3.58106.95107.10129.095.045.17
Accounts Payable15.0916.0515.8815.6317.2922.98
Income Tax Payable0.070.480.461.231.502.68
Other Current Liabilities51.0944.7231.7540.3338.0728.62
Total Current Liabilities69.84168.20155.20186.2861.9059.44
Long Term Debt260.65260.10260.03249.67373.94371.57
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.730.390.390.390.110.22
Other Liabilities2.082.322.372.412.022.34
Total Liabilities333.31431.00417.99438.75437.98433.56
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity55.7655.5755.2461.0665.6674.00
Total Shareholders Equity55.7655.5755.2461.0665.6674.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity55.7655.5755.2461.0665.6674.00
Total Liabilities & Stockholders Equity389.06486.57473.23499.80503.64507.56
Book Value Per Share8.568.548.559.5810.3211.68
Tangible Book Value Per Share-15.04-15.53-16.08-15.89-15.53-15.11
Full-Time Employees---613--
Price to Book Ratio1.951.622.082.903.863.27
Return on Assets-4.10-5.72-1.05-1.61-1.95-3.12
Return on Equity-30.12-43.88-11.94-16.86-18.73-26.54
Return on Invested Capital-0.28-0.85-2.10-2.61-2.514.42
Quick Ratio2.221.481.481.404.074.15
Current Ratio2.891.761.791.664.985.15

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.89-2.67-6.63-8.10-11.0319.71
Depreciation5.275.275.340.848.435.40
Other Funds (Non Cash)5.395.365.3915.266.07-12.01
Funds from Operations10.298.033.587.325.5414.18
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.98-5.36-9.147.884.10-4.54
Cash from Operating Activities11.262.67-5.5515.209.659.65
Capital Expenditures-1.06-1.21-1.65-1.38-1.08-1.55
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.06-1.21-1.65-1.38-1.08-1.55
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.00-1.570.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.00-1.570.000.00
Proceedsfrom Stock Options0.000.000.00-1.570.000.00
Issuance or Reduction of Debt, Net-103.230.00-20.16237.600.00-410.95
Change in Long Term Debt-103.230.00-20.16237.600.00-410.95
Issuance of Long Term Debt0.000.000.00237.600.000.00
Reduction of Long Term Debt-103.230.00-20.160.000.00-410.95
Net Financing Active Other Cash Flow-0.27-0.22-0.74-236.54-0.80237.59
Other Financing Activities Uses-0.27-0.22-0.741.15-0.19-0.71
Cash from Financing Activities-103.51-0.22-20.91-0.51-0.80-173.36
Exchange Rate Effect-0.380.47-0.21-0.03-0.364.24
Net Change in Cash-93.691.72-28.3213.287.40-161.03
Free Cash Flow11.172.24-5.7815.069.629.55
Price to Free Cash Flow3.614.244.114.766.556.83

Revenue breakdown

Consumables2024: 208.89M 2025: 212.71M
Delivery Systems2024: 125.40M 2025: 88.08M
Americas2024: 216.99M 2025: 203.98M
Asia Pacific2024: 45.67M 2025: 28.52M
EMEA2024: 71.63M 2025: 68.30M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.92%0.4M4.0M26.73K
2026-10-159.41%0.4M4.0M24.36K
2026-09-309.09%0.4M4.0M101.43K
2026-09-159.01%0.4M4.0M116.68K
2026-08-319.04%0.4M4.0M117.99K
2026-08-148.87%0.4M4.0M127.84K
2026-07-319.53%0.4M4.0M138.81K
2026-07-1511.03%0.4M4.0M139.40K
2026-06-3012.28%0.5M4.0M59.52K
2026-06-1515.70%0.6M4.0M47.86K
2026-05-2917.72%0.7M4.0M50.98K
2026-05-1520.48%0.8M4.0M45.57K
2026-04-3021.02%0.8M3.9M36.74K
2026-04-1521.76%0.8M3.6M34.01K
2026-03-3119.85%0.8M3.9M32.49K
2026-03-1319.84%0.8M3.9M30.18K
2026-02-2720.28%0.8M3.9M29.42K
2026-02-1320.36%0.8M3.9M28.55K
2026-01-3020.79%0.8M3.9M34.28K
2026-01-1521.66%0.8M3.8M41.45K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-09SCHEDULE 13G/ASEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-05SCHEDULE 13G/ASEC
2026-10-148-KCurrent report2026-10-14SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-068-KCurrent report2026-09-30SEC
2026-09-288-KCurrent report2026-09-22SEC
2026-09-108-KCurrent report2026-09-03SEC
2026-08-148-KCurrent report2026-08-10SEC
2026-08-12DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-12DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-22SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-31PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-22SEC
2026-07-27SCHEDULE 13G/ASEC
2026-07-17SCHEDULE 13GSEC
2026-07-13SCHEDULE 13G/ASEC
2026-07-08SCHEDULE 13G/ASEC
2026-06-228-KCurrent report2026-06-17SEC
2026-06-168-KCurrent report2026-06-10SEC
2026-05-218-K/A2026-05-05SEC
2026-05-20144Filing for proposed sale of securities under Rule 144.SEC
2026-05-128-KCurrent report2026-05-08SEC
2026-05-11SCHEDULE 13D/ASEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-05-068-KCurrent report2026-05-05SEC
2026-05-06SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Capricorn Fund Managers Ltd17.12%
BlackRock, Inc.6.57%
MILLENNIUM MANAGEMENT LLC5.82%
FMR LLC4.21%
VANGUARD CAPITAL MANAGEMENT LLC2.70%
Woodline Partners LP1.80%
Silver Point Capital L.P.1.23%
D. E. Shaw & Co., Inc.1.11%
GEODE CAPITAL MANAGEMENT, LLC0.69%
Glendon Capital Management LP0.49%

Funds

Fund% owned
iShares Convertible Bond ETF1.97%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.92%
Fidelity Growth Company Fund1.87%
Fidelity Small Cap Index Fund0.87%
Greenspring Income Opportunities Fund0.77%
VANGUARD CONSUMER STAPLES INDEX FUND0.75%
VANGUARD EXTENDED MARKET INDEX FUND0.71%
VANGUARD RUSSELL 2000 INDEX FUND0.46%
Fidelity Series Growth Company Fund0.36%
Fidelity Extended Market Index Fund0.33%

OakChart. SKIN. Cached 15 minutes.